日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cycle versus swap strategy after TNFi discontinuation in psoriatic arthritis and axial spondyloarthritis: a quasi-experimental study

银屑病关节炎和中轴型脊柱关节炎患者停用TNF抑制剂后,循环治疗策略与换药策略的比较:一项准实验研究

van Es, Ilse; Vriezekolk, Johanna E; den Broeder, Nathan; de Beijer, Lisan; den Broeder, Alfons A; van Herwaarden, Noortje; Mahler, Elien; Leijten, Emmerik F A

Challenges and Opportunities for Centers on Aging: Part 2 - Sustainability and Leadership

老龄化中心的挑战与机遇:第二部分——可持续性和领导力

Schipper, Lydia G; Fransen, Jaap; den Broeder, Alfons A; Van Riel, Piet L C M; Dobbs, Debra

Disease activity-guided dose optimization including discontinuation of TNF inhibitors in rheumatoid arthritis is effective for up to 10 years: an observational follow-up of the DRESS study

在类风湿性关节炎中,根据疾病活动度进行剂量优化(包括停用TNF抑制剂)的疗效可持续长达10年:DRESS研究的观察性随访结果

van der Togt, Céleste J T; den Broeder, Nathan; Boonstra, Marleen S; van der Maas, Aatke; den Broeder, Alfons A; van Herwaarden, Noortje

Fatigue patterns surrounding biologic disease-modifying antirheumatic drug injection in patients with an inflammatory rheumatic disease: an ecological momentary assessment study

炎症性风湿病患者接受生物制剂类疾病修饰抗风湿药物注射后疲劳模式:一项生态瞬时评估研究

van Lint, Jette A; Vriezekolk, Johanna E; Jessurun, Naomi T; den Broeder, Alfons A; van den Bemt, Bart J F; Huiskes, Victor J B

Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib

考比司他人群药代动力学及其对抗癌药物奥拉帕尼药代动力学的影响

Overbeek, Joanneke K; van Erp, Nielka P; Burger, David M; den Broeder, Alfons A; Koolen, Stijn L W; Huitema, Alwin D R; Ter Heine, Rob

Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial

利妥昔单抗超低剂量治疗类风湿性关节炎的长期临床和放射学疗效及安全性:REDO试验的观察性扩展研究

den Broeder, Nathan; Verhoef, Lise; de Man, Yaël A; Kok, Marc R; Thurlings, Rogier; van der Weele, Wilfred; van den Bemt, Bart Jf; van den Hoogen, Frank Hj; van der Maas, Aatke; den Broeder, Alfons A

Functional limitations of people with rheumatoid arthritis or axial spondyloarthritis and severe functional disability: a cross-sectional descriptive study

类风湿性关节炎或中轴型脊柱关节炎伴严重功能障碍患者的功能限制:一项横断面描述性研究

Teuwen, Max M H; van Weely, Salima F E; Vliet Vlieland, Thea P M; Douw, Thom; van Schaardenburg, Dirkjan; den Broeder, Alfons A; van Tubergen, Astrid M; van Wissen, Maria A T; van den Ende, Cornelia H M; Gademan, Maaike G J

Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study

炎症性风湿病中生物制剂和靶向合成DMARDs成本效益应用的考量因素:一项伞状综述和国际德尔菲研究的结果

van der Togt, Céleste J T; Van den Bemt, Bart; Aletaha, Daniel; Alten, Rieke; Chatzidionysiou, Katerina; Galloway, James; Isaac, John; Mulleman, Denis; Verschueren, P; Vulto, Arnold G; Welsing, Paco M J; Verhoef, Lise; den Broeder, Alfons A

What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis

在类风湿性关节炎的达标治疗策略中,最佳治疗目标是什么?一项系统评价和荟萃回归分析的结果

Messelink, Marianne A; den Broeder, Alfons A; Marinelli, Florine E; Michgels, Edwin; Verschueren, P; Aletaha, Daniel; Tekstra, Janneke; Welsing, Paco M J

Seroconversion after a third COVID-19 vaccine is affected by rituximab dose but persistence is not in patients with rheumatoid arthritis

在类风湿性关节炎患者中,接种第三剂新冠疫苗后的血清转化受利妥昔单抗剂量影响,但血清转化的持续性不受影响。

van der Togt, Céleste J T; Ten Cate, David F; van den Bemt, Bart J F; Rahamat-Langendoen, Janette; den Broeder, Nathan; den Broeder, Alfons A